Craig Philips
Presidente presso KINETA, INC.
Patrimonio netto: 61 098 $ in data 30/04/2024
Profilo
Craig W.
Philips is the founder of Abacus Bioscience, Inc. He currently holds the position of Chief Executive Officer & Director at Kv1.3 Therapeutics, Inc., Director at CBI Co., Ltd., Governor at Kineta Viral Hemorrhagic Fever LLC, and President at Kineta, Inc. (Washington) and Kineta, Inc. He previously held the position of President at CTI BioPharma Corp., Vice President & General Manager at Bayer HealthCare Pharmaceuticals, Inc., and Vice President & General Manager at Berlex Pharmaceuticals, Inc. He received his undergraduate degree and MBA from The Ohio State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KINETA, INC.
0.87% | 25/04/2024 | 95 465 ( 0.87% ) | 61 098 $ | 30/04/2024 |
Posizioni attive di Craig Philips
| Società | Posizione | Inizio |
|---|---|---|
| CBI CO., LTD. | Direttore/Membro del Consiglio | - |
| KINETA, INC. | Presidente | 01/01/2013 |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Presidente | 01/01/2013 |
Abacus Bioscience, Inc.
 Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Fondatore | - |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Amministratore Delegato | - |
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Craig Philips
| Società | Posizione | Fine |
|---|---|---|
| CTI BIOPHARMA CORP. | Presidente | - |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Corporate Officer/Principal | 01/04/2008 |
| Berlex Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/12/2006 |
Formazione di Craig Philips
| The Ohio State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CBI CO., LTD. | Producer Manufacturing |
| Aziende private | 8 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
| Berlex Pharmaceuticals, Inc. | |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Health Technology |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Health Technology |
Abacus Bioscience, Inc.
Abacus Bioscience, Inc. BiotechnologyHealth Technology Abacus Bioscience, Inc. develops developing novel immunotherapeutic treatments for cancer and antiviral diseases. The company was founded by Edward A Clark and Craig W Philips and is headquartered in Seattle, WA. | Health Technology |
| Kineta, Inc. |
- Borsa valori
- Insiders
- Craig Philips